Results 171 to 180 of about 4,021,724 (320)

Theory of chemical kinetics. Progress report, May 1, 1976--April 30, 1977

, 1977
John Ross
openalex   +2 more sources

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

<i>HSS Journal</i> and Its Commitment to DEI: A Progress Report. [PDF]

HSS J
Barber LA, Jacobson J, Cornell CN.
europepmc   +1 more source

Endogenous Product Choice : A Progress Report [PDF]

Empirical models of differentiated product demand are widely used by both academics and practitioners. While these methods treat carefully the potential endogeneity of price, until recently they have assumed the number and characteristics of the products
Crawford, Gregory S.
core  

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Work-in-progress report: a prospective, multi-institutional observational study on intraoperative lymph node dissection for thymic epithelial malignancies with radiologically invasive features. [PDF]

Mediastinum
Hamaji M, Nishikawa S, Koyasu S, Yutaka Y, Kojima F, Nakanishi T, Kono T, Yamada Y, Hijiya K, Ohata K, Kikuchi R, Miyamoto E, Nakagawa T, Omasa M, Miyahara R, Bando T, Date H.   +16 more
europepmc   +1 more source

Radioecology of Natural Systems Sixteenth Technical Progress Report, Aug 1, 1977 - July 31, 1978

, 1978
F. W. Whicker
openalex   +2 more sources

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source

Establishment of clinical exercise physiology as a regulated healthcare profession in the UK: a progress report. [PDF]

BMJ Open Sport Exerc Med
Jones H, Crozier A, George K, Miller G, Whyte GP, Rycroft J, Scott A, Buckley JP, McGregor G, Askew CD, Jack S, Birkett S, Broom DR, Tolfrey K, Campbell A, Skelton DA, Steenkamp L, Savage J, Green DJ.   +18 more
europepmc   +1 more source

The "State of Implementation" Progress Report (SIPREP): a pilot demonstration of a navigation system for implementation. [PDF]

Implement Sci Commun, 2020
Miech EJ, Larkin A, Lowery JC, Butler AJ, Pettey KM, Rattray NA, Penney LS, Myers J, Damush TM.   +8 more
europepmc   +1 more source